@Biff234523 This is a very small study, sponsored by NovaVax, so I think we should be a little skeptical. Also, there is nothing in the paper as to whether the difference in IgG3 vs IgG4 levels actually makes a difference in real-world booster effectiveness. They didn't study that.
It's time to repost this explanation from Scott Galloway of how the U.S disproportionately benefits from trade with Canada, in pure economic shareholder value terms. Added bonus, he shuts up Kevin O'Leary who is speechless. #cdnpoli#ableg
https://t.co/RXOUeSpps8